The search found 4062 results.
Whitepaper
The DEA Interim Final Rule (IFR) allowing EPCS is designed to reduce drug diversion and fraud by ensuring providers are legally authorized to prescribe controlled substances and they use proper authentication methods to sign orders. This paper describes how Imprivata Confirm ID addresses several DEA requirements for EPCS, including provider identity proofing, two-factor authentication, and auditing.
Press
Imprivata Confirm ID, the First Comprehensive Product that Simplifies Adoption of Regulatory Requirements for EPCS, Helps Providers Address Inefficiencies and Potential Fraud Caused by Paper-Based Prescriptions
News
Fred Gebhart
February 10, 2015
Pharmacists across New York are processing some of their last paper prescriptions. As of March 27, all Rxs filled by New York pharmacists must be electronic, including those for controlled substances. With a few minor exceptions, paper is about to become history in one of the largest Rx markets in the country.
News
The Joint Commission, which accredits healthcare organizations, has reversed its long ban on physicians and certain other clinicians using text messaging to place orders related to patient care, citing technology advances that enable more secure communication. But users must comply with a list of requirements, including the use of encryption.
News
Aaron Miri, who most recently served as chief information officer at Dallas-based Walnut Hill Medical Center, has taken a job as CIO at Imprivata, the healthcare security company.